T
Tiffany Hung
Researcher at Genentech
Publications - 19
Citations - 9008
Tiffany Hung is an academic researcher from Genentech. The author has contributed to research in topics: Histone H3 & Histone code. The author has an hindex of 12, co-authored 18 publications receiving 8128 citations. Previous affiliations of Tiffany Hung include Howard Hughes Medical Institute & Stanford University.
Papers
More filters
Journal ArticleDOI
Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.
Li Tai Fang,Bin Zhu,Yongmei Zhao,Wanqiu Chen,Zhaowei Yang,Zhaowei Yang,Liz Kerrigan,K J. Langenbach,Maryellen de Mars,Charles Lu,Kenneth Idler,Howard Jacob,Yuanting Zheng,Luyao Ren,Ying Yu,Erich Jaeger,Gary P. Schroth,Ogan D Abaan,Keyur Talsania,Justin B. Lack,Tsai-wei Shen,Zhong Chen,Seta Stanbouly,Bao Tran,Jyoti Shetty,Yuliya Kriga,Daoud Meerzaman,Cu Nguyen,Virginie Petitjean,Marc Sultan,Margaret C. Cam,Monika Mehta,Tiffany Hung,Eric Peters,Rasika Kalamegham,Sayed Mohammad Ebrahim Sahraeian,Marghoob Mohiyuddin,Yunfei Guo,Lijing Yao,Lei Song,Hugo Y. K. Lam,Jiri Drabek,Petr Vojta,Roberta Maestro,Daniela Gasparotto,Sulev Kõks,Sulev Kõks,Ene Reimann,Andreas Scherer,Jessica Nordlund,Ulrika Liljedahl,Roderick V. Jensen,Mehdi Pirooznia,Zhipan Li,Chunlin Xiao,Stephen T. Sherry,Rebecca Kusko,Malcolm Moos,Eric F. Donaldson,Zivana Tezak,Baitang Ning,Weida Tong,Jing Li,Penelope Duerken-Hughes,Claudia Catalanotti,Shamoni Maheshwari,Joe Shuga,Winnie S. Liang,Jonathan J Keats,Jonathan Adkins,Erica Tassone,Victoria Zismann,Timothy K. McDaniel,Jeffrey M. Trent,Jonathan Foox,Daniel Butler,Christopher E. Mason,Huixiao Hong,Leming Shi,Charles Wang,Wenming Xiao +80 more
TL;DR: Reference call sets obtained from paired tumor-normal genomic DNA (gDNA) samples derived from a breast cancer cell line-which is highly heterogeneous, with an aneuploid genome, and enriched in somatic alterations-and a matched lymphoblastoid cell line.
Journal ArticleDOI
Pre‐ and post‐treatment blood‐based genomic landscape of patients with ROS1 or NTRK fusion‐positive solid tumours treated with entrectinib
Rafal Dziadziuszko,Tiffany Hung,Kun Wang,Voleak Choeurng,Alexander Drilon,Robert C. Doebele,Fabrice Barlesi,Charlie Wu,Lucas Dennis,Joel Skoletsky,Ryan Woodhouse,Meijuan Li,Ching-Wei Chang,B. Simmons,Todd Riehl,Timothy M. Willson +15 more
TL;DR: It is concluded that F1L CDx is a clinically valid complement to tissue‐based testing to identify patients who may benefit from entrectinib and those with acquired resistance mutations associated with disease progression.
Posted ContentDOI
Whole Genome and Exome Sequencing Reference Datasets from A Multi-center and Cross-platform Benchmark Study
Yongmei Zhao,Li Tai Fang,Tsai-wei Shen,Sulbha Choudhari,Keyur Talsania,Xiongfong Chen,Jyoti Shetty,Yuliya Kriga,Bao Tran,Bin Zhu,Zhong Chen,Wangqiu Chen,Charles Wang,Erich Jaeger,Daoud Meerzaman,Charles W. Lu,Kenneth Idler,Yuanting Zheng,Leming Shi,Virginie Petitjean,Marc Sultan,Tiffany Hung,Eric Peters,Jiri Drabek,Petr Vojta,Roberta Maestro,Daniela Gasparotto,Sulev Kõks,Ene Reimann,Andreas Scherer,Jessica Nordlund,Ulrika Liljedahl,Jonathan Foox,Christopher E. Mason,Chunlin Xiao,Wenming Xiao +35 more
TL;DR: In this paper, a comprehensive benchmarking study using both whole-genome (WGS) and whole-exome sequencing (WES) data sets generated from two well-characterized reference samples: a human breast cancer cell line (HCC1395) and a matched normal cell line derived from B lymphocytes.